Physician

Manisha Tiwari, M.D.

According to 2025 Medicare claims, Manisha Tiwari, M.D. (NPI: 1265786115) practices internal medicine in the Rocky Mount, NC market, with the plurality of this provider's patient population coming from Edgecombe, NC. This provider's primary affiliated billing organization is VIDANT MEDICAL GROUP LLC (NPI: 1477648731; TIN: 383740839) and primary practice location at 27886-1935. Tiwari is affiliated with the Coastal Plains Network, LLC (ACO ID: A2684), participating under the MSSP model.

Tiwari's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 295 traditional Medicare patients, billed 3,900 HCPCS/CPT codes, and received $111,972 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 20,564 prescription claims across 941 beneficiaries totaling $1,603,678 in drug costs, led by Ozempic (Semaglutide). DME data shows 39 claims. Open Payments data shows 22 records totaling $428. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $32,411 to $111,972. Similarly, Part D prescription costs have moved sharply higher in recent years, from $12,394 to $1,603,678. In contrast, DME billing represents a smaller volume and moved sharply higher in recent years, from $1,135 to $6,146.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	141	977	$32,411
2018	267	2,723	$77,482
2019	328	4,362	$113,592
2020	270	3,791	$87,040
2021	243	2,663	$74,381
2022	294	3,623	$110,685
2023	267	3,602	$105,403
2024	295	3,900	$111,972

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	29	235	$12,394
2016	21	71	$12,248
2017	131	676	$55,453
2018	296	3,673	$168,347
2019	393	5,797	$381,242
2020	357	8,515	$569,330
2021	409	8,424	$644,482
2022	545	12,145	$985,028
2023	769	15,513	$1,362,485
2024	941	20,564	$1,603,678

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	29	$241
2019	13	25	$284
2020	21	82	$736
2021	12	37	$423
2022	N/R	54	$5,834
2023	N/R	97	$13,215
2024	N/R	39	$640

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	280	592	$80
80061	Blood test, lipids (cholesterol and triglycerides)	142	148	$13
80053	Blood test, comprehensive group of blood chemicals	201	332	$10
36415	Insertion of needle into vein for collection of blood sample	219	482	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	195	335	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ozempic	Semaglutide	242	8,368	$271,635
Jardiance	Empagliflozin	145	7,365	$146,695
Januvia	Sitagliptin Phosphate	122	5,982	$111,833
Tradjenta	Linagliptin	156	6,067	$106,910
Rybelsus	Semaglutide	66	2,880	$91,835

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
K0001	Standard wheelchair	Y	N/R	19	$345
A4253	Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips	N	N/R	20	$294

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	22	$428	Novo Nordisk Inc
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Manisha Tiwari, M.D.?

Tedicare shows public-source Medicare data for Manisha Tiwari, M.D. (NPI 1265786115), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Manisha Tiwari, M.D. have ACO affiliation data?

Manisha Tiwari, M.D. is shown with ACO affiliation data for Coastal Plains Network, LLC (MSSP, ACO ID A2684).

What billing organization is linked to Manisha Tiwari, M.D.?

Manisha Tiwari, M.D. is linked to VIDANT MEDICAL GROUP LLC (billing NPI 1477648731) in the available physician profile data.

Does Manisha Tiwari, M.D. have Open Payments data?

Manisha Tiwari, M.D. has 22 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.